Background Vasomotor symptoms (VMS), characterized by hot flashes and night sweats,
are the most commonly reported symptoms associated with estrogen deficiency during …

… IPA) were searched using the keywords hot flashes, vasomotor symptoms, menopause, and
paroxetine. In PubMed, MeSH terms were used for paroxetine, menopause, and hot flashes. …

… Guidance for industry: estrogen and estrogen/progestin drug products to treat vasomotor
symptoms and vulvar and vaginal atrophy symptoms. Recommendations for clinical evaluation. …

… In postmenopausal women treated for menopausal vasomotor symptoms, paroxetine 7.5 mg
significantly reduces the number of nighttime awakenings attributed to vasomotor symptoms …

… of moderate to severe postmenopausal vasomotor symptoms. Citation1 This article reviews
available data for using paroxetine for the treatment of bothersome menopausal symptoms. …

… RCTs on the effect of paroxetine compared with placebo or no treatment for perimenopausal
and postmenopausal women who experienced moderate-to-severe vasomotor symptoms. …

… Vasomotor symptoms (VMS) are the number one complaint of most menopausal women.
VMS are disruptive to women during the day and at night, which leads to poor sleep, anxiety, …

… that low-dose paroxetine 7.5 mg reduced the frequency and severity of vasomotor symptoms
(VMS) … whether treatment with paroxetine 7.5 mg affected weight, sexual function, or both. …

… majority of treatment responses … paroxetine to treat postmenopausal hot flashes and
emphasize the importance of considering effective, alternative treatments for vasomotor symptoms…

… The following search terms were used: bazedoxifene vasomotor and paroxetine vasomotor.
… for BZA vasomotor yielded 38 citations. The initial search for paroxetine vasomotor yielded …